Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Pépin, Jacques ^a   Chakra, Claire Nour Abou ^a   Pépin, Eric ^a   Nault, Vincent ^a   Valiquette, Louis ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIGEN;

ARTICLE; CALCULATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; MATHEMATICAL MODEL; PATHOGEN LOAD; POPULATION GROWTH; PREVALENCE; PROBABILITY; PUBLIC HEALTH; SAFETY; SENSITIVITY ANALYSIS; UNSAFE INJECTION; VACCINATION; VIRUS INFECTION; VIRUS TRANSMISSION; ADVERSE EFFECTS; COST OF ILLNESS; CROSS INFECTION; HEALTH; HISTORY; HIV INFECTIONS; TRANSMISSION; VIRUS DISEASES;

COST OF ILLNESS; CROSS INFECTION; GLOBAL HEALTH; HEPATITIS B; HEPATITIS C; HISTORY, 21ST CENTURY; HIV INFECTIONS; HUMANS; INJECTIONS; PREVALENCE; VIRUS DISEASES;

EID: 84902589968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099677     Document Type: Article

References (47)

1. Hauri AM, Armstrong GL, Hutin YJF (2004) The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 16: 7-16. (Pubitemid 38096122)
2. Hutin YJF, Hauri AM, Armstrong GL (2003) Use of injections in healthcare settings worldwide, 2000; literature review and regional estimates. BMJ 323: 1075.
3. Hauri AJ, Armstrong GL, Hutin YJF (2004) Contaminated injections in health care settings. In: M . Ezzati, et al. editors. Comparative quantification of health risks. Geneva, World Health Organization.
4. The SIGN Alliance. Available: http://www.who.int/injection-safety/sign/ en/Accessed 2014 April 25.
5. Pepin J, Abou Chakra CN, Pepin E, Nault V (2013) Evolution of the global burden of unsafe medical injections, 2000-2010. PLoS One 2013;e80948.
6. United Nations Department of Economic and Social Affairs. World Population Prospects, the 2010 revision. Available: http://esa.un.org/unpd/wpp/ Excel-Data/population.htm Accessed 2014 April 25.
7. Jagger J, Puro V, De Carli G (2002) Occupational transmission of Hepatitis C virus. JAMA 288: 1469-1470.
8. Centers for Disease Control and Prevention (2001) Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for post-exposure prophylaxis. Morb Mort Wkly Rep 50 (RR-11): 1-52.
9. Gerberding JL (2003) Occupational exposure to HIV in healthcare settings. N Engl J Med 348: 826-833.
10. Bell DM (1997) Occupational risk of HIV infections in healthcare workers: an overview. Am J Med 102 (Suppl 5B): 9-15.
11. Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, et al. (1993) Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Int Med 118: 913-919. (Pubitemid 23164127)
12. Ippolito G, Puro V, De Carli G (1993) The risk of occupational HIV infection among healthcare workers: Italian Multicenter Study. Arch Int Med 153: 1451-1458. (Pubitemid 23191052)
13. Baggaley RF, Boily MC, White RG, Alary M (2006) Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 20: 805-812. (Pubitemid 43731561)
14. Kaplan EH, Heimer R (1992) A model-based estimate of HIV-1 infectivity via needle sharing. J Acq Immun Def Syndr 5: 1116-1118.
15. Hudgens MG, Longini IM, Halloran ME, Choopanya K, Vanichseni S, et al. (2001) Estimating the HIV-1 transmission probability in injecting drug users in Thailand. Appl Stat 50: 1-14.
16. Hudgens MG, Longini IM, Vanichseni S, Hu DJ, Kitayaporn D, et al. (2002) Subtype specific transmission probabilities for HIV-1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 155: 159-168. (Pubitemid 34072739)
17. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, et al. (1997) A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 337: 1485-1490. (Pubitemid 27495773)
18. Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, et al. (2005) Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 41: 1423-1430. (Pubitemid 41579983)
19. Gerberding JL (1995) Management of occupational exposures to blood-borne viruses. N Eng J Med 332: 444-451.
20. Werner BG, Grady GF (1982) Accidental Hepatitis B -surface antigen positive inoculations: use of e antigen to estimate infectivity. Ann Intern Med 97: 367-369. (Pubitemid 12061585)
21. UNAIDS (2010) UNAIDS report on the global AIDS epidemic. Geneva, UNAIDS.
22. Measure DHS. Demographic and Health Surveys. Available: http://dhsprogram.com/ Accessed 2014 April 25.
23. Reid S (2009) Increase in clinical prevalence of AIDS implies increase in unsafe medical injections. Int J STD AIDS 20: 295-299.
24. United States Census Bureau. HIV AIDS Surveillance Data Base. Available: http://www.census.gov/population/international/data/hiv/interactive/ Accessed 2014 April 25.
25. Njobvu P, McGill P, Kerr H, Jellis J, Pobee J (1998) Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 25: 1553-1559. (Pubitemid 28364762)
26. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, et al. (1998) Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 76: 480-486. (Pubitemid 28227988)
27. Tharyan P, Ramalingam S, Kannangai R, Sridharan G, Muliyil J, et al. (2003) Prevalence of HIV infection in psychiatric patients attending a general hospital in Tamil Nadu, south India. AIDS Care 15: 197-205. (Pubitemid 36470004)
28. Chang LW, Osei-Kwasi M, Boakye D, Aidoo S, Hagy A, et al. (2002) HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa. J Acquir Immune Defic Syndr 29: 511-516. (Pubitemid 34456343)
29. Solomon SS, Pulimi S, Rodriguez II, Chaguturu SK, Satish Kumar SK, et al. (2004) Dried blood spots are an acceptable and useful HIV surveillance tool in a remote developing world setting. Int J STD AIDS 15: 658-661. (Pubitemid 39331290)
30. Francesconi P, Fabiani M, Dente MG, Lukwiya M, Okwey R, et al. (2001) HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS 15: 2445-2450. (Pubitemid 34014614)
31. Pilcher CD, Price MA, Hoffman IF, Galvin S, Martinson FEA, et al. (2004) Frequent detection of acute primary HIV infection in men in Malawi. AIDS 18: 517-524. (Pubitemid 38365880)
32. Croce F, Fedeli P, Dahoma M, Deho L, Ramsan M, et al. (2007) Risk factors for HIV/AIDS in a low HIV prevalence site of sub-Saharan Africa. Trop Med Int Health 12: 1011-1017. (Pubitemid 47414936)
33. Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, et al. (2006) Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 193: 9-15. (Pubitemid 43032494)
34. Banura C, Francheschi S, van Doorn LJ, Arslan A, Wabwire-Mangen F, et al. (2008) Infection with human papillomavirus and HIV among young women in Kampala, Uganda. J Infect Dis 197: 555-562. (Pubitemid 351321533)
35. Ivers LC, Freedberg KA, Mukherjee JS (2007) Provider-initiated HIV testing in rural Haiti: low rate of missed opportunities for diagnosis of HIV in a primary care clinic. AIDS Res Ther 4: 28.
36. Van Geertruyden JP, Mulenga M, Mwananyanda L, Chalwe V, Moerman F, et al. (2006) HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. J Infect Dis 194: 917-925. (Pubitemid 44454077)
37. Wanyenze RK, Nawavvu C, Namale AS, Mayanja B, Bunnell R, et al. (2008) Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ 86: 302-309. (Pubitemid 351521857)
38. Bebell LM, Pilcher CD, Dorsey G, Havlir D, Kamya MR, et al. (2010) Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS 24: 1945-1952.
39. Shisana O, Connolly C, Rehle TM, Mehtar S, Dana P (2008) HIV risk exposure among South African children in public health facilities. AIDS Care 20: 755-763.
40. Horwood C, Butler LM, Vermaak K, Rollins N, Haskins L, et al. (2011) Disease profile of children under 5 years attending primary health care clinics in a high HIV prevalence setting in South Africa. Trop Med Int Health 16: 42-52.
41. Avert. South Africa HIV & AIDS statistics. Available: http://www.avert.org/south-africa-hiv-aids-statistics.htm Accessed 2013 December 1.
42. Hanafiah KH, Groeger J, Flaxman AD, Wiersma ST, et al. (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to hepatitis C virus seroprevalence. Hepatology doi:10.1002/hep.26141.
43. Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of Hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 2212-2219.
44. Ott JJ, Stevens GA, Wiersma ST (2012) The risk of perinatal Hepatitis B virus transmission. Hepatits B e Antigen (HBeAg) prevalence estimates for all regions of the world regions. BMC Infect Dis 12: 131.
45. World Health Organization. Immunization surveillance, assessment and monitoring. Available: http://www.who.int/immunization-monitoring/data/data- subject/en/index.html Accessed 2014 April 25.
46. Schmid GP, Buvé A, Mugyenyi P, Garnett GP, Hayes RJ, et al. (2004) Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 363: 882-888.
47. Gisselquist D, Upham G, Potterat JJ (2006) Efficiency of Human Immunodeficiency Virus transmission through injections and other medical procedures: evidence, estimates, and unfinished business. Infect Control Hosp Epidemiol 27: 944-952. (Pubitemid 44449254)